Pleasanton, CA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a clinical-stage biopharmaceutical company focused on developing and commercializing ...
The MarketWatch News Department was not involved in the creation of this content. -- Financing co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund ...
The modulation of RNA splicing by small molecules has emerged as a promising strategy for treating pathogenic infections, human genetic diseases, and cancer; however, the principles by which splicing ...
Splicing made headlines earlier this week when researchers from the National Institutes of Health reported that telomere-induced changes to the splicing machinery appear to be a major mechanism of ...
Pleasanton, CA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTCQB) PK: PKBO), announced that it was awarded US Patent No. 11,691,982 B2 entitled “Thailanstatin ...
In the Jan. 12, 2009, online edition of the Proceedings of the National Academy of Sciences, researchers showed that morpholino oligomers can be used to transform red blood cells and reverse a form of ...
A $1.6million grant from the National Institute of Health (MD, USA) has been awarded to study the underlying biochemistry and crystallography of RNA splicing using bacteria from hot springs. Roughly ...
The structure of a key enzyme involved in protein production is revealed by cryo-electron microscopy (cryo-EM). Using cryo-EM, researchers at Goethe University (Frankfurt, Germany) shed light on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback